Just how long it will be before we can call it ‘game over’ for a healthcare model that’s predominantly dependent on patented pharmaceutical drugs is anyone’s guess. But I’m tempted to say that time is likely to be a lot sooner than many think. Sky high pricing, lack of affordability, lack of effectiveness against the most common diseases, unnecessary side-effects and the self-serving nature of the patent model are just a few of the problems that pharma currently faces. A leading clinical researcher that’s spent over 40 years doing clinical and drug research speaks out. Check out what Milton Packer MD (no relation to Kerry!) has to say about it in our lead piece.
We also cover a Big Food/Regulator discussion on what happens to food regulation after Brexit. The biggest news is that most of the things that Big Food wants to know about are unknown, such as whether or not EFSA opinions will be obeyed or ignored and how import and export controls will be managed.
Our news snippets this week bring good news on the German Government’s commitment to maintain glyphosate bans and Singapore’s progressive approach to organic certification for urban and indoor agriculture.
In health, naturally
Rob Verkerk, PhD Founder, executive & scientific director
You may copy, reproduce, reprint or forward any content on the condition that attribution is made clearly to Alliance for Natural Health International including date and link to original content.
Alliance for Natural Health International. The Atrium, Curtis Road, Dorking, Surrey RH4 1XA, UK
